Welcome to
On Feet Nation
Thomas Shaw Online
Zola Montero Online
seomypassion12 Online
Layne Online
PP Online
Data Entry Inc Online
Ritha Haak Online
asimseo Online
Phillip Online
India’s apex drug regulator on Tuesday approved the phase 2 and 3 clinical trials of Covid vaccine candidate by Pune-based Gennova, which has shown very encouraging results in the early-stage trials.
Importantly, this mRNA-based vaccine will likely be compared with Covishiled, and not placebo while the trials will include about 4,400 participants at 22-24 sites across the country. Also, it may be the first vaccine to be introduced in India specifically designed against the delta variant of SARS CoV 2–the most dominant strain of the virus in India and elsewhere.
Read more at https://www.newindianexpress.com/nation/2021/aug/24/mrna-vaccine-by...
© 2024 Created by PH the vintage. Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation